Cholecystectomy
Conditions
Keywords
transgastric cholecystectomy
Brief summary
The study will document being able to successfully perform transgastric cholecystectomy (laparoscopic visualization) using a small collection of study surgical tools.
Interventions
DEVICENOTES GEN 1 Toolbox
Articulating Hook Knife, Articulating Snare, Articulating Needle Knife Articulating Graspers, Articulating Biopsy Forceps, Steerable Flex Trocar with Rotary Access Needle, Flexible Bipolar Hemostasis Forceps, Flexible Maryland Dissector, and Tissue Apposition System.
Sponsors
Ethicon Endo-Surgery
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Men and women will be enrolled in this study who: * Are willing to give consent and comply with evaluation and treatment schedule, able to understand and complete study questionnaires; * At least 18 years of age; * Have a clinical diagnosis of gallbladder disease indicated for cholecystectomy; * ASA Classification I or II (Appendix II); and * Have a negative serum pregnancy test (for women of childbearing potential); * Have the study procedure attempted.
Exclusion criteria
* BMI \> 35; * Use of immunosuppressive medications (within 6 months of surgery; single burst dosages and inhalable steroids are acceptable); * Suspicion of gallbladder cancer, tumor, polyps, or mass; * Acute cholecystitis or acute pancreatitis; * Presence of common bile duct stones; * History of open abdominal surgery; * Evidence of abdominal abscess or mass; * Diffuse peritonitis; * Use of anticoagulants or anti-platelet agents (use of daily cardio protective doses of aspirin, up to 81 mg/day, is acceptable and shall not constitute an exclusion criterion) or the presence of coagulopathy; * Clinical diagnosis of sepsis; * History of peritoneal trauma; * Co-morbid condition(s) that could limit the subject's ability to participate in the study or to comply with follow-up requirements, or that could impact the scientific integrity of the trial; * Planned concurrent surgical procedure; * Prior or planned major surgical procedure within 30 days before or after study procedure; * Previous diagnosis of intra-abdominal adhesions; * Participation in any other investigational device or drug trial that has not completed the primary endpoint or that clinically interferes with the current study endpoints; * Previously enrolled in the current series of 4 trials investigating the EES NOTES GEN1 Toolbox; or * Any condition which precludes compliance with the study (Investigator discretion).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of procedures completed | 1 Day | Day of surgery only - study complete at end of prodecure. |
Countries
United States
Outcome results
None listed